spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 30 May 2025
Diakonos Oncology Closes $20 Million Financing to Accelerate Phase 2 Glioblastoma Clinical Development Program and Expand Use of Innovative Dendritic Cell Platform for Studies in Other Indications
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 May 2025
Isotopia and Cardirad Announce Launch of Isoprotrace(R) in Sweden and Denmark, Expanding Access to Advanced Prostate Cancer Imaging
Biopharmaceuticals Radiology Oncology Product Launch
 HSMN NewsFeed - 23 May 2025
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 May 2025
Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*--Addressing Nationwide Shortage of the Essential Drug
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 May 2025
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 May 2025
Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2025
Ted Myles Joins Cellarity as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2025
Lilly Announces Transitions in Executive Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2025
PAQ Therapeutics Appoints Andrew Krivoshik, MD, PhD, as Chief Medical Officer, Announces Addition of Eric Rubin, MD, and Piro Lito MD, PhD, to Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 May 2025
PAQ Therapeutics Announces $39 Million Series B Financing and Initiates Phase 1 Trial to Advance Novel Approach Addressing KRAS-Driven Cancers with High Unmet Need
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 May 2025
Spinogenix Announces FDA-Authorized Expanded Access Program for SPG302, the First Synaptic Regenerative Therapy to Treat ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 1 May 2025
Altesa BioSciences announces Katharine Knobil, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2025
Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Apr 2025
Lutris Pharma Announces the Appointment of Seasoned Life Science Executive, Sumant Ramachandra, M.D., Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2025
FDA Grants Orphan Drug Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis with Polyangiitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Apr 2025
Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 9 Apr 2025
Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies
Biopharmaceuticals Oncology Venture Capital
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!